Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 110

1.

The Role of Biosimilars in Uveitis: Long-Term Real-World Outcomes of the Switch From Original to Biosimilar TNF-Alpha Inhibitors.

Fabiani C, Vitale A, Emmi G, Sgheri A, Lopalco G, Sota J, Guerriero S, Iannone F, Frediani B, Vannozzi L, Bianco MT, Giovannini V, Tosi GM, Cantarini L.

Front Pharmacol. 2019 Dec 9;10:1468. doi: 10.3389/fphar.2019.01468. eCollection 2019.

2.

Histopathologic Features of Fibrotic Knee Synovitis in a Young Adult With Seronegative Rheumatoid Arthritis.

Venerito V, Cazzato G, Lopalco G, Fornaro M, Righetti G, Urso L, Cimmino A, Iannone F.

J Clin Rheumatol. 2019 Dec 24. doi: 10.1097/RHU.0000000000001247. [Epub ahead of print] No abstract available.

PMID:
31876841
3.

Efficacy of baricitinib on refractory skin papulosquamous rash in a patient with systemic lupus erythematosus.

Fornaro M, Coladonato L, Venerito V, Cacciapaglia F, Lopalco G, Iannone F.

Rheumatology (Oxford). 2019 Nov 25. pii: kez442. doi: 10.1093/rheumatology/kez561. [Epub ahead of print] No abstract available.

PMID:
31761943
4.

Efficacy of monoclonal anti-tumour necrosis factor-α antibodies in uveitic macular oedema.

Tosi GM, Vitale A, Rigante D, Sota J, Emmi G, Lopalco G, Guerriero S, Iannone F, Vannozzi L, Bitossi A, Frediani B, Cantarini L, Fabiani C.

Clin Exp Rheumatol. 2019 Oct 17. [Epub ahead of print]

PMID:
31694738
5.

Comorbid fibromyalgia impairs the effectiveness of biologic drugs in patients with psoriatic arthritis.

Iannone F, Nivuori M, Fornaro M, Venerito V, Cacciapaglia F, Lopalco G.

Rheumatology (Oxford). 2019 Oct 25. pii: kez505. doi: 10.1093/rheumatology/kez505. [Epub ahead of print]

PMID:
31652315
6.

Anakinra for corticosteroid-dependent and colchicine-resistant pericarditis: The IRAP (International Registry of Anakinra for Pericarditis) study.

Imazio M, Andreis A, De Ferrari GM, Cremer PC, Mardigyan V, Maestroni S, Luis SA, Lopalco G, Emmi G, Lotan D, Marcolongo R, Lazaros G, De Biasio M, Cantarini L, Dagna L, Cercek AC, Pivetta E, Varma B, Berkson L, Tombetti E, Iannone F, Prisco D, Caforio ALP, Vassilopoulos D, Tousoulis D, De Luca G, Giustetto C, Rinaldi M, Oh JK, Klein AL, Brucato A, Adler Y.

Eur J Prev Cardiol. 2019 Oct 15:2047487319879534. doi: 10.1177/2047487319879534. [Epub ahead of print]

PMID:
31610707
7.

Response to: 'Response to: "Influence of changes in cholesterol levels and disease activity on the 10-year cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients" by Fornaro et al' by Agca et al.

Fornaro M, Cacciapaglia F, Venerito V, Lopalco G, Iannone F.

Ann Rheum Dis. 2019 Oct 11. pii: annrheumdis-2019-216407. doi: 10.1136/annrheumdis-2019-216407. [Epub ahead of print] No abstract available.

PMID:
31604705
8.

Efficacy of baricitinib on refractory skin papulosquamous rash in a patient with systemic lupus erythematosus.

Fornaro M, Coladonato L, Venerito V, Cacciapaglia F, Lopalco G, Iannone F.

Rheumatology (Oxford). 2019 Oct 10. pii: kez442. doi: 10.1093/rheumatology/kez442. [Epub ahead of print] No abstract available.

PMID:
31600396
9.

Anakinra Drug Retention Rate and Predictive Factors of Long-Term Response in Systemic Juvenile Idiopathic Arthritis and Adult Onset Still Disease.

Sota J, Rigante D, Ruscitti P, Insalaco A, Sfriso P, de Vita S, Cimaz R, Lopalco G, Emmi G, La Torre F, Fabiani C, Olivieri AN, Cattalini M, Cammelli D, Gallizzi R, Alessio M, Manna R, Viapiana O, Frassi M, Pardeo M, Maier A, Salvarani C, Talarico R, Mosca M, Colafrancesco S, Priori R, Maggio MC, Gaggiano C, Grosso S, De Benedetti F, Vitale A, Giacomelli R, Cantarini L.

Front Pharmacol. 2019 Aug 23;10:918. doi: 10.3389/fphar.2019.00918. eCollection 2019.

10.

Real-world effectiveness of apremilast in multirefractory mucosal involvement of Behçet's disease.

Lopalco G, Venerito V, Leccese P, Emmi G, Cantarini L, Lascaro N, Di Scala G, Fabiani C, Rigante D, Iannone F.

Ann Rheum Dis. 2019 Dec;78(12):1736-1737. doi: 10.1136/annrheumdis-2019-215437. Epub 2019 Aug 10. No abstract available.

PMID:
31401548
11.

Paradoxical Pustular Psoriasis in a Patient With Psoriatic Arthritis on Secukinumab Treatment.

Abbruzzese A, Venerito V, Lopalco G, Fornaro M, Giannotta M, Iannone F.

J Clin Rheumatol. 2019 Jun 11. doi: 10.1097/RHU.0000000000001076. [Epub ahead of print] No abstract available.

PMID:
31192857
12.

Influence of changes in cholesterol levels and disease activity on the 10 years cardiovascular risk estimated with different algorithms in rheumatoid arthritis patients.

Fornaro M, Cacciapaglia F, Venerito V, Lopalco G, Iannone F.

Ann Rheum Dis. 2019 May 29. pii: annrheumdis-2019-215715. doi: 10.1136/annrheumdis-2019-215715. [Epub ahead of print] No abstract available.

PMID:
31142479
13.

Different drug survival of first line tumour necrosis factor inhibitors in radiographic and non-radiographic axial spondyloarthritis: a multicentre retrospective survey.

Lopalco G, Venerito V, Cantarini L, Emmi G, Salaffi F, Di Carlo M, Tafuri S, Gentileschi S, Di Scala G, Nivuori M, Cacciapaglia F, Galeazzi M, Lapadula G, Iannone F.

Clin Exp Rheumatol. 2019 Sep-Oct;37(5):762-767. Epub 2019 Apr 16.

PMID:
31025925
14.

Long-Term Retention Rate of Anakinra in Adult Onset Still's Disease and Predictive Factors for Treatment Response.

Vitale A, Cavalli G, Colafrancesco S, Priori R, Valesini G, Argolini LM, Baldissera E, Bartoloni E, Cammelli D, Canestrari G, Sota J, Cavallaro E, Massaro MG, Ruscitti P, Cipriani P, De Marchi G, De Vita S, Emmi G, Ferraccioli G, Frassi M, Gerli R, Gremese E, Iannone F, Lapadula G, Lopalco G, Manna R, Mathieu A, Montecucco C, Mosca M, Piazza I, Piga M, Pontikaki I, Romano M, Rossi S, Rossini M, Silvestri E, Stagnaro C, Talarico R, Tincani A, Viapiana O, Vitiello G, Galozzi P, Sfriso P, Gaggiano C, Rigante D, Dagna L, Giacomelli R, Cantarini L.

Front Pharmacol. 2019 Apr 2;10:296. doi: 10.3389/fphar.2019.00296. eCollection 2019.

15.

Unveiling the Efficacy, Safety, and Tolerability of Anti-Interleukin-1 Treatment in Monogenic and Multifactorial Autoinflammatory Diseases.

Bettiol A, Lopalco G, Emmi G, Cantarini L, Urban ML, Vitale A, Denora N, Lopalco A, Cutrignelli A, Lopedota A, Venerito V, Fornaro M, Vannacci A, Rigante D, Cimaz R, Iannone F.

Int J Mol Sci. 2019 Apr 17;20(8). pii: E1898. doi: 10.3390/ijms20081898. Review.

16.

Efficacy and safety of certolizumab pegol and golimumab in the treatment of non-infectious uveitis.

Tosi GM, Sota J, Vitale A, Rigante D, Emmi G, Lopalco G, Guerriero S, Orlando I, Iannone F, Frediani B, Angotti R, Messina M, Galeazzi M, Vannozzi L, Cantarini L, Fabiani C.

Clin Exp Rheumatol. 2019 Jul-Aug;37(4):680-683. Epub 2019 Apr 3.

17.

Adalimumab Accounts for Long-Term Control of Noninfectious Uveitis Also in the Absence of Concomitant DMARD Treatment: A Multicenter Retrospective Study.

Bitossi A, Bettiol A, Silvestri E, Di Scala G, Bacherini D, Lopalco G, Venerito V, Iannone F, Vitale A, Tosi GM, Prisco D, Rizzo S, Fabiani C, Cantarini L, Virgili G, Vannozzi L, Emmi G.

Mediators Inflamm. 2019 Feb 10;2019:1623847. doi: 10.1155/2019/1623847. eCollection 2019.

18.

The right place of interleukin-1 inhibitors in the treatment of Behçet's syndrome: a systematic review.

Bettiol A, Silvestri E, Di Scala G, Amedei A, Becatti M, Fiorillo C, Lopalco G, Salvarani C, Cantarini L, Soriano A, Emmi G.

Rheumatol Int. 2019 Jun;39(6):971-990. doi: 10.1007/s00296-019-04259-y. Epub 2019 Feb 25.

PMID:
30799530
19.

Efficacy of anti-tumour necrosis factor-α monoclonal antibodies in patients with non-infectious anterior uveitis.

Fabiani C, Vitale A, Rigante D, Emmi G, Lopalco G, Sota J, Vannozzi L, Guerriero S, Bitossi A, Orlando I, Franceschini R, Frediani B, Galeazzi M, Iannone F, Tosi GM, Cantarini L.

Clin Exp Rheumatol. 2019 Mar-Apr;37(2):301-305. Epub 2019 Jan 18.

20.

Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic Arthritis.

Sota J, Insalaco A, Cimaz R, Alessio M, Cattalini M, Gallizzi R, Maggio MC, Lopalco G, La Torre F, Fabiani C, Pardeo M, Olivieri AN, Sfriso P, Salvarani C, Gaggiano C, Grosso S, Bracaglia C, De Benedetti F, Rigante D, Cantarini L.

Front Pharmacol. 2019 Jan 8;9:1526. doi: 10.3389/fphar.2018.01526. eCollection 2018.

21.

A Bayesian mixed treatment comparison of efficacy of biologics and small molecules in early rheumatoid arthritis.

Venerito V, Lopalco G, Cacciapaglia F, Fornaro M, Iannone F.

Clin Rheumatol. 2019 May;38(5):1309-1317. doi: 10.1007/s10067-018-04406-z. Epub 2019 Jan 10. Review.

PMID:
30628014
22.

Splenic Infarction as Only Manifestation of Antiphospholipid Syndrome in a Patient With Rheumatoid Arthritis.

Venerito V, Lopalco G, Cacciapaglia F, Coladonato L, Iannone F.

J Clin Rheumatol. 2018 Dec 28. doi: 10.1097/RHU.0000000000000964. [Epub ahead of print] No abstract available.

PMID:
30601167
23.

Epidemiological profile of non-infectious uveitis from the rheumatologist's perspective: a survey from two tertiary referral centres in Italy.

Lopalco G, Venerito V, Sota J, Rigante D, Guerriero S, Orlando I, Franceschini R, Favale R, Lapadula G, Castelli B, Frediani B, Galeazzi M, La Torre F, Iannone F, Tosi GM, Fabiani C, Cantarini L.

Clin Exp Rheumatol. 2018 Nov-Dec;36(6 Suppl 115):68-73. Epub 2018 Dec 12.

PMID:
30582503
24.

Sarcopenia in Patients with Rheumatic Diseases: Prevalence and Associated Risk Factors.

Barone M, Viggiani MT, Anelli MG, Fanizzi R, Lorusso O, Lopalco G, Cantarini L, Di Leo A, Lapadula G, Iannone F.

J Clin Med. 2018 Dec 1;7(12). pii: E504. doi: 10.3390/jcm7120504.

25.

Lipids and Atherogenic Indices Fluctuation in Rheumatoid Arthritis Patients on Long-Term Tocilizumab Treatment.

Cacciapaglia F, Anelli MG, Rinaldi A, Fornaro M, Lopalco G, Scioscia C, Lapadula G, Iannone F.

Mediators Inflamm. 2018 Oct 14;2018:2453265. doi: 10.1155/2018/2453265. eCollection 2018.

26.

Critical regulation of Th17 cell differentiation by serum amyloid-A signalling in Behcet's disease.

Lucherini OM, Lopalco G, Cantarini L, Emmi G, Lopalco A, Venerito V, Vitale A, Iannone F.

Immunol Lett. 2018 Sep;201:38-44. doi: 10.1016/j.imlet.2018.10.013. Epub 2018 Oct 29.

PMID:
30385329
27.

Long-term effectiveness and safety of switching from originator to biosimilar infliximab in patients with Behçet's disease.

Lopalco G, Venerito V, Cantarini L, Emmi G, Prisco D, Iannone F.

Intern Emerg Med. 2019 Aug;14(5):719-722. doi: 10.1007/s11739-018-1970-3. Epub 2018 Oct 25. No abstract available.

PMID:
30361849
28.

Correction to: Long-term efficacy and safety of golimumab in the treatment of multirefractory Behçet's disease.

Vitale A, Emmi G, Lopalco G, Fabiani C, Gentileschi S, Silvestri E, Di Scala G, Iannone F, Frediani B, Galeazzi M, Lapadula G, Rigante D, Cantarini L.

Clin Rheumatol. 2019 Jan;38(1):267. doi: 10.1007/s10067-018-4302-0.

PMID:
30242638
29.

Tomographic regression of pulmonary rheumatoid nodules under baricitinib therapy.

Venerito V, Lopalco G, Anelli MG, Cacciapaglia F, Iannone F.

Rheumatology (Oxford). 2019 Mar 1;58(3):440. doi: 10.1093/rheumatology/key294. No abstract available.

PMID:
30212893
30.

The Presence of Uveitis Is Associated with a Sustained Response to the Interleukin (IL)-1 Inhibitors Anakinra and Canakinumab in Behçet's Disease.

Fabiani C, Vitale A, Rigante D, Emmi G, Lopalco G, Di Scala G, Sota J, Orlando I, Franceschini R, Frediani B, Galeazzi M, Iannone F, Tosi GM, Cantarini L.

Ocul Immunol Inflamm. 2018 Aug 27:1-7. doi: 10.1080/09273948.2018.1511810. [Epub ahead of print]

PMID:
30148652
31.

Prompt Clinical Response to Secukinumab in Patients with Axial Spondyloarthritis: Real Life Observational Data from Three Italian Referral Centers.

Gentileschi S, Vitale A, Rigante D, Lopalco G, Emmi G, Orlando I, Di Scala G, Sota J, Fabiani C, Frediani B, Galeazzi M, Lapadula G, Iannone F, Cantarini L.

Isr Med Assoc J. 2018 Jul;20(7):438-441.

32.

Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients.

Fabiani C, Vitale A, Rigante D, Emmi G, Bitossi A, Lopalco G, Sota J, Guerriero S, Orlando I, Gentileschi S, Iannone F, Frediani B, Galeazzi M, Vannozzi L, Tosi GM, Cantarini L.

Clin Rheumatol. 2019 Feb;38(2):407-415. doi: 10.1007/s10067-018-4228-6. Epub 2018 Aug 11.

PMID:
30099655
33.

Correlation of Serum Amyloid-A Levels, Clinical Manifestations, Treatment, and Disease Activity in Patients with Behçet's Disease.

Sota J, Vitale A, Rigante D, Orlando I, Lucherini OM, Simpatico A, Lopalco G, Franceschini R, Galeazzi M, Frediani B, Fabiani C, Tosi GM, Cantarini L.

Isr Med Assoc J. 2018 Aug;20(8):517-521.

34.

Influence of baseline modified Rheumatic Disease Comorbidity Index (mRDCI) on drug survival and effectiveness of biological treatment in patients affected with Rheumatoid arthritis, Spondyloarthritis and Psoriatic arthritis in real-world settings.

Iannone F, Salaffi F, Fornaro M, Di Carlo M, Gentileschi S, Cantarini L, Lopalco G.

Eur J Clin Invest. 2018 Nov;48(11):e13013. doi: 10.1111/eci.13013. Epub 2018 Aug 23.

PMID:
30079593
35.

Use of Interleukin-1 Blockers in Pericardial and Cardiovascular Diseases.

Emmi G, Urban ML, Imazio M, Gattorno M, Maestroni S, Lopalco G, Cantarini L, Prisco D, Brucato A.

Curr Cardiol Rep. 2018 Jun 14;20(8):61. doi: 10.1007/s11886-018-1007-6. Review.

PMID:
29904899
36.

Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study.

Sota J, Vitale A, Insalaco A, Sfriso P, Lopalco G, Emmi G, Cattalini M, Manna R, Cimaz R, Priori R, Talarico R, de Marchi G, Frassi M, Gallizzi R, Soriano A, Alessio M, Cammelli D, Maggio MC, Gentileschi S, Marcolongo R, La Torre F, Fabiani C, Colafrancesco S, Ricci F, Galozzi P, Viapiana O, Verrecchia E, Pardeo M, Cerrito L, Cavallaro E, Olivieri AN, Paolazzi G, Vitiello G, Maier A, Silvestri E, Stagnaro C, Valesini G, Mosca M, de Vita S, Tincani A, Lapadula G, Frediani B, De Benedetti F, Iannone F, Punzi L, Salvarani C, Galeazzi M, Angotti R, Messina M, Tosi GM, Rigante D, Cantarini L; “Working Group” of Systemic Autoinflammatory Diseases of SIR (Italian Society of Rheumatology).

Clin Rheumatol. 2018 Aug;37(8):2233-2240. doi: 10.1007/s10067-018-4119-x. Epub 2018 May 17.

PMID:
29770930
37.

Efficacy of adalimumab and infliximab in recalcitrant retinal vasculitis inadequately responsive to other immunomodulatory therapies.

Fabiani C, Sota J, Rigante D, Vitale A, Emmi G, Lopalco G, Vannozzi L, Guerriero S, Bitossi A, Orlando I, Franceschini R, Frediani B, Galeazzi M, Iannone F, Tosi GM, Cantarini L.

Clin Rheumatol. 2018 Oct;37(10):2805-2809. doi: 10.1007/s10067-018-4133-z. Epub 2018 May 15.

PMID:
29766375
38.

Predictors of sustained clinical response in patients with Behçet's disease-related uveitis treated with infliximab and adalimumab.

Fabiani C, Vitale A, Rigante D, Emmi G, Lopalco G, Sota J, Vannozzi L, di Scala G, Guerriero S, Orlando I, Franceschini R, Capozzoli M, Frediani B, Galeazzi M, Iannone F, Tosi GM, Cantarini L.

Clin Rheumatol. 2018 Jun;37(6):1715-1720. doi: 10.1007/s10067-018-4092-4. Epub 2018 Apr 18.

PMID:
29671190
39.

Management of idiopathic recurrent pericarditis in adults and in children: a role for IL-1 receptor antagonism.

Brucato A, Emmi G, Cantarini L, Di Lenarda A, Gattorno M, Lopalco G, Marcolongo R, Imazio M, Martini A, Prisco D.

Intern Emerg Med. 2018 Jun;13(4):475-489. doi: 10.1007/s11739-018-1842-x. Epub 2018 Apr 9. Review.

PMID:
29633070
40.

Long-term retention rates of adalimumab and infliximab in non-infectious intermediate, posterior, and panuveitis.

Fabiani C, Vitale A, Emmi G, Bitossi A, Lopalco G, Sota J, Guerriero S, Orlando I, Capozzoli M, Fusco F, Rana F, Iannone F, Frediani B, Galeazzi M, Vannozzi L, Tosi GM, Cantarini L.

Clin Rheumatol. 2019 Jan;38(1):63-70. doi: 10.1007/s10067-018-4069-3. Epub 2018 Apr 3.

PMID:
29611087
41.

Ten-Year Retention Rate of Infliximab in Patients with Behçet's Disease-Related Uveitis.

Fabiani C, Sota J, Vitale A, Emmi G, Vannozzi L, Bacherini D, Lopalco G, Guerriero S, Venerito V, Orlando I, Franceschini R, Fusco F, Frediani B, Galeazzi M, Iannone F, Tosi GM, Cantarini L.

Ocul Immunol Inflamm. 2019;27(1):34-39. doi: 10.1080/09273948.2017.1391297. Epub 2017 Nov 3.

PMID:
29099660
42.

Pain Processing and Vegetative Dysfunction in Fibromyalgia: A Study by Sympathetic Skin Response and Laser Evoked Potentials.

de Tommaso M, Ricci K, Libro G, Vecchio E, Delussi M, Montemurno A, Lopalco G, Iannone F.

Pain Res Treat. 2017;2017:9747148. doi: 10.1155/2017/9747148. Epub 2017 Sep 28.

43.

Ustekinumab efficacy and safety in mucocutaneous multi-refractory Behçet's disease.

Lopalco G, Fabiani C, Venerito V, Lapadula G, Iannone F, Cantarini L.

Clin Exp Rheumatol. 2017 Nov-Dec;35 Suppl 108(6):130-131. Epub 2017 Sep 7. No abstract available.

PMID:
28980903
44.

Long-term efficacy and safety of the interleukin-1 inhibitors anakinra and canakinumab in refractory Behçet disease uveitis and concomitant bladder papillary carcinoma.

Orlando I, Vitale A, Rigante D, Lopalco G, Fabiani C, Cantarini L.

Intern Med J. 2017 Sep;47(9):1086-1088. doi: 10.1111/imj.13538. No abstract available.

PMID:
28891187
45.

Cumulative retention rate of adalimumab in patients with Behçet's disease-related uveitis: a four-year follow-up study.

Fabiani C, Sota J, Vitale A, Rigante D, Emmi G, Vannozzi L, Bacherini D, Lopalco G, Guerriero S, Gentileschi S, Capozzoli M, Franceschini R, Frediani B, Galeazzi M, Iannone F, Tosi GM, Cantarini L.

Br J Ophthalmol. 2018 May;102(5):637-641. doi: 10.1136/bjophthalmol-2017-310733. Epub 2017 Aug 26.

PMID:
28844047
46.

Intravitreal Dexamethasone Implant as an Adjunct Weapon for Severe and Refractory Uveitis in Behçet's Disease.

Fabiani C, Emmi G, Lopalco G, Vannozzi L, Bacherini D, Guerriero S, Franceschini R, Frediani B, Iannone F, Marco Tosi G, Rigante D, Cantarini L.

Isr Med Assoc J. 2017 Jul;19(7):415-419.

47.

Biological therapies for the treatment of Behçet's disease-related uveitis beyond TNF-alpha blockade: a narrative review.

Sota J, Rigante D, Lopalco G, Frediani B, Franceschini R, Galeazzi M, Iannone F, Tosi GM, Fabiani C, Cantarini L.

Rheumatol Int. 2018 Jan;38(1):25-35. doi: 10.1007/s00296-017-3775-5. Epub 2017 Jul 27. Review.

PMID:
28752230
48.

Certolizumab Pegol treatment in Behcet's disease with different organ involvement: A multicenter retrospective observational study.

Lopalco G, Emmi G, Gentileschi S, Guerriero S, Vitale A, Silvestri E, Becatti M, Cavallo I, Fabiani C, Frediani B, Iannone F, Cantarini L.

Mod Rheumatol. 2017 Nov;27(6):1031-1035. doi: 10.1080/14397595.2017.1285857. Epub 2017 Feb 21.

PMID:
28712320
49.

Response to Interleukin-1 Inhibitors in 140 Italian Patients with Adult-Onset Still's Disease: A Multicentre Retrospective Observational Study.

Colafrancesco S, Priori R, Valesini G, Argolini L, Baldissera E, Bartoloni E, Cammelli D, Canestrari G, Cantarini L, Cavallaro E, Cavalli G, Cerrito L, Cipriani P, Dagna L, Marchi G, Vita S, Emmi G, Ferraccioli G, Frassi M, Galeazzi M, Gerli R, Giacomelli R, Gremese E, Iannone F, Lapadula G, Lopalco G, Manna R, Mathieu A, Montecucco C, Mosca M, Piazza I, Piga M, Pontikaki I, Romano M, Rossi S, Rossini M, Ruscitti P, Silvestri E, Stagnaro C, Talarico R, Tincani A, Viapiana O, Vitiello G, Fabris F, Bindoli S, Punzi L, Galozzi P, Sfriso P.

Front Pharmacol. 2017 Jun 13;8:369. doi: 10.3389/fphar.2017.00369. eCollection 2017.

50.

Systemic Steroid Sparing Effect of Intravitreal Dexamethasone Implant in Chronic Noninfectious Uveitic Macular Edema.

Fabiani C, Vitale A, Emmi G, Lopalco G, Vannozzi L, Bacherini D, Guerriero S, Favale RA, Fusco F, Franceschini R, Frediani B, Iannone F, Galeazzi M, Tosi GM, Cantarini L.

J Ocul Pharmacol Ther. 2017 Sep;33(7):549-555. doi: 10.1089/jop.2017.0034. Epub 2017 May 30.

PMID:
28557602

Supplemental Content

Loading ...
Support Center